semaglutide shortage Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders Semaglutide Market Size, Share &

A cost-effective alternative: MediFits role in making GLP-1s accessible MediFit: An affordable GLP-1 access program for employers and employees While some employer plans cant afford to cover GLP-1 medications for every employee, that doesnt mean access should be out of reach

Methionine, Inositol, Choline (MIC) + Carnitine/B12 or otherwise referred to as Lipo-C when made by compounding pharmacists

Zhang, Y., Gao, S., Liang, K., Wu, Z., Yan, X., & Liu, W

Retatrutide targets three receptors simultaneously: GLP-1, GIP, and glucagon

In the case of HFmrEF and HFpEF, an additional criterion such as elevated serum levels of natriuretic peptides, structural heart diseases, or diastolic dysfunction must be considered for diagnosis